Literature DB >> 22626505

Listeria infection in patients on anti-TNF treatment: report of two cases and review of the literature.

Cândida Abreu1, Fernando Magro, Filipe Vilas-Boas, Susana Lopes, Guilherme Macedo, António Sarmento.   

Abstract

Listeria monocytogenes is an aerobic gram positive intracellular bacillus, predominantly affecting pregnant women, immunocompromised patients and old individuals. Invasive listeriosis, meningitis and meningoencephalitis, bacteraemia with or without joint, eye or heart focalization are clinical manifestations of the disease. Anti-TNF-α drugs blocking the host's response against various microorganisms, particularly intracellular agents like Listeria monocytogenes, increase the risk of disease. We report two cases of L. monocytogenes meningitis in ulcerative colitis patients under infliximab plus steroids. One patient is HIV-1 infected. A review of reported invasive listeriosis cases under anti-TNF drugs is also showed.
Copyright © 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22626505     DOI: 10.1016/j.crohns.2012.04.018

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  13 in total

1.  Septicemic listeriosis during adalimumab- and golimumab-based treatment for ulcerative colitis: case presentation and literature review.

Authors:  Ryoko Horigome; Hiroki Sato; Terasu Honma; Shuji Terai
Journal:  Clin J Gastroenterol       Date:  2019-06-20

Review 2.  Adverse events in IBD: to stop or continue immune suppressant and biologic treatment.

Authors:  Leon P McLean; Raymond K Cross
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2014-02-04       Impact factor: 3.869

Review 3.  Immunomodulatory Agents for Treatment of Patients with Inflammatory Bowel Disease (Review safety of anti-TNF, Anti-Integrin, Anti IL-12/23, JAK Inhibition, Sphingosine 1-Phosphate Receptor Modulator, Azathioprine / 6-MP and Methotrexate).

Authors:  Lindsey Sattler; Stephen B Hanauer; Lisa Malter
Journal:  Curr Gastroenterol Rep       Date:  2021-12-16

4.  Cellular immune responses in HIV-negative immunodeficiency with anti-interferon-γ antibodies and opportunistic intracellular microorganisms.

Authors:  Jiraprapa Wipasa; Panuwat Wongkulab; Kriangkrai Chawansuntati; Romanee Chaiwarit; Khuanchai Supparatpinyo
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

5.  Diversity of Listeria monocytogenes Strains of Clinical and Food Chain Origins in Belgium between 1985 and 2014.

Authors:  S Bertrand; P J Ceyssens; M Yde; K Dierick; F Boyen; J Vanderpas; R Vanhoof; W Mattheus
Journal:  PLoS One       Date:  2016-10-10       Impact factor: 3.240

Review 6.  Methods for rapid diagnosis of meningitis etiology in adults.

Authors:  Victoria Poplin; David R Boulware; Nathan C Bahr
Journal:  Biomark Med       Date:  2020-04-09       Impact factor: 2.851

7.  Listeria monocytogenes Meningitis After Treatment With Infliximab in an 8-Year-Old Pediatric Patient With Crohn's Disease.

Authors:  Uzma Rani; Ajay Rana
Journal:  ACG Case Rep J       Date:  2021-07-09

8.  Emergence of sporadic non-clustered cases of hospital-associated listeriosis among immunocompromised adults in southern Taiwan from 1992 to 2013: effect of precipitating immunosuppressive agents.

Authors:  Chun-Yuan Lee; Hung-Chin Tsai; Calvin M Kunin; Susan Shin-Jung Lee; Kuan-Sheng Wu; Yao-Shen Chen
Journal:  BMC Infect Dis       Date:  2014-03-19       Impact factor: 3.090

9.  Listeria Monocytogenes Septicemia and Meningitis Caused by Listeria Enteritis Complicating Ulcerative Colitis.

Authors:  Takahiro Inoue; Toshinao Itani; Noriko Inomata; Kazuya Hara; Ikuhisa Takimoto; Shunya Iseki; Kensuke Hamada; Kanna Adachi; Shunsuke Okuyama; Yukari Shimada; Motohito Hayashi; Jun Mimura
Journal:  Intern Med       Date:  2017-09-06       Impact factor: 1.271

10.  Listeria Meningitis during Infliximab-based Treatment for Ulcerative Colitis.

Authors:  Atsunori Tsuchiya; Shuji Terai
Journal:  Intern Med       Date:  2018-03-30       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.